These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38555751)
1. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series. Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751 [TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review. Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902 [TBL] [Abstract][Full Text] [Related]
3. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer. Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456 [TBL] [Abstract][Full Text] [Related]
4. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes. Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656 [TBL] [Abstract][Full Text] [Related]
5. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M; Rudra S; Bates JE; Remick JS; Joshi NP; Woody NM; Awan M; Geiger JL; Shreenivas A; Samsa J; Ward MC; Schmitt NC; Patel MR; Higgins KA; Teng Y; Steuer CE; Shin DM; Liu Y; Ahmed R; Koyfman SA JAMA Oncol; 2024 Jul; 10(7):896-904. PubMed ID: 38780927 [TBL] [Abstract][Full Text] [Related]
6. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer. Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158 [TBL] [Abstract][Full Text] [Related]
7. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. Caudell JJ; Ward MC; Riaz N; Zakem SJ; Awan MJ; Dunlap NE; Isrow D; Hassanzadeh C; Vargo JA; Heron DE; Marcrom S; Boggs DH; Reddy CA; Dault J; Bonner JA; Higgins KA; Beitler JJ; Koyfman SA; Machtay M; Yao M; Trotti AM; Siddiqui F; Lee NY; Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):606-617. PubMed ID: 29413274 [TBL] [Abstract][Full Text] [Related]
8. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas. Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748 [TBL] [Abstract][Full Text] [Related]
9. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N; Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182 [TBL] [Abstract][Full Text] [Related]
10. Wide-field pulsed reduced dose rate radiotherapy (PRDR) for recurrent ependymoma in pediatric and young adult patients. Mohindra P; Robins HI; Tomé WA; Hayes L; Howard SP Anticancer Res; 2013 Jun; 33(6):2611-8. PubMed ID: 23749916 [TBL] [Abstract][Full Text] [Related]
11. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy. Witt JS; Musunuru HB; Bayliss RA; Howard SP J Neurooncol; 2019 Jan; 141(1):103-109. PubMed ID: 30392090 [TBL] [Abstract][Full Text] [Related]
12. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127 [TBL] [Abstract][Full Text] [Related]
13. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis. Roesch J; Oertel M; Wegen S; Trommer M; Schleifenbaum J; Hering D; Mäurer M; Knippen S; Dobiasch S; Waltenberger M; von der Grün J; Medenwald D; Süß C; Hoeck M; Käsmann L; Fleischmann DF; Rühle A; Nicolay NH; Fabian A; Löser A; Heß S; Tamaskovics B; Vinsensia M; Hecht M; Radiother Oncol; 2023 Apr; 181():109380. PubMed ID: 36273736 [TBL] [Abstract][Full Text] [Related]
14. Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer. Chen AM; Harris JP; Nabar R; Tjoa T; Haidar Y; Armstrong WB Radiother Oncol; 2024 Jul; 196():110278. PubMed ID: 38636710 [TBL] [Abstract][Full Text] [Related]
15. Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx. Nam H; Ahn YC; Yang K; Oh D; Noh JM Cancer Res Treat; 2022 Jan; 54(1):96-108. PubMed ID: 33781049 [TBL] [Abstract][Full Text] [Related]
16. Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection. Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Bornedal S; Wennberg B; Friesland S Radiat Oncol; 2020 Jun; 15(1):147. PubMed ID: 32513217 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic. Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083 [TBL] [Abstract][Full Text] [Related]
18. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925 [TBL] [Abstract][Full Text] [Related]
19. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial. Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy. Hayashi K; Koto M; Ikawa H; Hagiwara Y; Tsuji H; Ogawa K; Kamada T Radiother Oncol; 2019 Jul; 136():148-153. PubMed ID: 31015117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]